{"name": "Westaim",
 "permalink": "westaim",
 "crunchbase_url": "http://www.crunchbase.com/company/westaim",
 "homepage_url": "http://www.westaim.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 21 11:56:42 UTC 2010",
 "updated_at": "Thu Jan 21 12:07:17 UTC 2010",
 "overview": "\u003Cp\u003EWestaim Corporation invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim holds a 75 per cent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Westaim\u0026#8217;s common shares are listed on The Toronto Stock Exchange under the trading symbol WED.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       33],
      "assets/images/resized/0007/4318/74318v1-max-150x150.jpg"],
     [[167,
       37],
      "assets/images/resized/0007/4318/74318v1-max-250x250.jpg"],
     [[167,
       37],
      "assets/images/resized/0007/4318/74318v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.westaim.com/News/PressReleases/PressReleaseDetails/2009/WestaimAnnouncesAmalgamationAgreementwithNUCRYSTPharmaceuticals1121225/default.aspx",
    "source_description": "Westaim Announces Amalgamation Agreement with NUCRYST Pharmaceuticals",
    "acquired_year": 2009,
    "acquired_month": 11,
    "acquired_day": 10,
    "company":
     {"name": "NUCRYST Pharmaceuticals",
      "permalink": "nucryst-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            45],
           "assets/images/resized/0007/4316/74316v1-max-150x150.jpg"],
          [[250,
            76],
           "assets/images/resized/0007/4316/74316v1-max-250x250.jpg"],
          [[269,
            82],
           "assets/images/resized/0007/4316/74316v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}